Literature DB >> 1784274

Comparative study of the expression of Rb and p53 genes in human colorectal cancers, colon carcinoma cell lines and synchronized human fibroblasts.

M L Gope1, M Chun, R Gope.   

Abstract

We have compared the expression of the retinoblastoma (Rb) and p53 genes in normal human fibroblasts, colon carcinoma cell lines, matched pairs of colorectal tumor tissues and adjacent normal mucosa and in synchronized human diploid fibroblast cell line WI38. The increased expression of Rb and p53 RNA was observed in a majority of colorectal cancers in comparison to adjacent normal mucosa and is accompanied by proportional increase in the expression of histone H3 gene. The Rb and p53 RNA levels varied significantly between the various colon carcinoma cell lines. However, we found that the expression of Rb and p53 RNA is regulated differently in cell cycle synchronized normal human fibroblasts. The Rb mRNA level did not change with the position in the cell cycle and did not differ significantly whether the cells were serum deprived or in 10% serum. But p53 mRNA expression follows the same pattern as histone H3 mRNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1784274     DOI: 10.1007/bf02424576

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

1.  SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family.

Authors:  J W Ludlow; J A DeCaprio; C M Huang; W H Lee; E Paucha; D M Livingston
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

2.  Increased expression of the retinoblastoma gene in human colorectal carcinomas relative to normal colonic mucosa.

Authors:  R Gope; M A Christensen; A Thorson; H T Lynch; T Smyrk; C Hodgson; D M Wildrick; M L Gope; B M Boman
Journal:  J Natl Cancer Inst       Date:  1990-02-21       Impact factor: 13.506

3.  Coordinate regulation of multiple histone mRNAs during the cell cycle in HeLa cells.

Authors:  M Plumb; J Stein; G Stein
Journal:  Nucleic Acids Res       Date:  1983-04-25       Impact factor: 16.971

4.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

5.  Simultaneous monitoring of P53 protein and DNA content of colorectal adenocarcinomas by flow cytometry.

Authors:  Y Remvikos; P Laurent-Puig; R J Salmon; G Frelat; B Dutrillaux; G Thomas
Journal:  Int J Cancer       Date:  1990-03-15       Impact factor: 7.396

6.  Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.

Authors:  A B DeLeo; G Jay; E Appella; G C Dubois; L W Law; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

7.  Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas.

Authors:  C J Der; G M Cooper
Journal:  Cell       Date:  1983-01       Impact factor: 41.582

8.  Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

Authors:  J W Harbour; S L Lai; J Whang-Peng; A F Gazdar; J D Minna; F J Kaye
Journal:  Science       Date:  1988-07-15       Impact factor: 47.728

9.  Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein.

Authors:  L V Crawford; D C Pim; E G Gurney; P Goodfellow; J Taylor-Papadimitriou
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

10.  Increased concentration of an apparently identical cellular protein in cells transformed by either Abelson murine leukemia virus or other transforming agents.

Authors:  V Rotter; M A Boss; D Baltimore
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

View more
  11 in total

1.  Increased histone H1 phosphorylation and relaxed chromatin structure in Rb-deficient fibroblasts.

Authors:  R E Herrera; F Chen; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

2.  Altered structure and expression of RB1 gene and increased phosphorylation of pRb in human vestibular schwannomas.

Authors:  R Thomas; P D Antony Herold Prabhu; J Mathivanan; D Sivakumar; P N Jayakumar; B Indira Devi; S Satish; K V R Sastry; R Gope
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

3.  Altered structure and deregulated expression of the tumor suppressor gene retinoblastoma (RB1) in human brain tumors.

Authors:  J Mathivanan; K Rohini; Mohan L Gope; B Anandh; Rajalakshmi Gope
Journal:  Mol Cell Biochem       Date:  2007-02-23       Impact factor: 3.396

4.  Regulation of RB transcription in vivo by RB family members.

Authors:  Deborah L Burkhart; Lynn K Ngai; Caitlin M Roake; Patrick Viatour; Chellappagounder Thangavel; Victoria M Ho; Erik S Knudsen; Julien Sage
Journal:  Mol Cell Biol       Date:  2010-01-25       Impact factor: 4.272

5.  The retinoblastoma protein (Rb) as an anti-apoptotic factor: expression of Rb is required for the anti-apoptotic function of BAG-1 protein in colorectal tumour cells.

Authors:  T J Collard; B C Urban; H A Patsos; A Hague; P A Townsend; C Paraskeva; A C Williams
Journal:  Cell Death Dis       Date:  2012-10-11       Impact factor: 8.469

6.  Loss of heterozygosity of the p53 gene and deregulated expression of its mRNA and protein in human brain tumors.

Authors:  K Rohini; J Mathivanan; P D Antony Herold Prabhu; D K Subbakrishna; M L Gope; B A Chandramouli; S Sampath; B Anandh; R Gope
Journal:  Mol Cell Biochem       Date:  2006-12-16       Impact factor: 3.842

7.  Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer.

Authors:  Weiqiang Zhao; Cheng C Huang; Gregory A Otterson; Marino E Leon; Yan Tang; Konstantin Shilo; Miguel A Villalona
Journal:  J Oncol       Date:  2012-04-30       Impact factor: 4.375

8.  Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation.

Authors:  N el-Mahdani; J C Vaillant; M Guiguet; S Prévot; V Bertrand; C Bernard; R Parc; G Béréziat; B Hermelin
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Comparative analysis of Rb1, P16 and ER as diagnostic, prognostic and potential targets for therapeutic agents in ovarian epithelial tumors: an immunohistochemical study of 130 ovarian carcinomas.

Authors:  Donna Catherine Ferguson; Daniel Jerad Long; Megan Christine Smith; Laura Deeanne Craig-Owens; Julie Means; Oluwole Fadare; Mohamed Mokhtar Desouki
Journal:  J Ovarian Res       Date:  2015-06-05       Impact factor: 4.234

Review 10.  Tumor Suppressors Having Oncogenic Functions: The Double Agents.

Authors:  Neerajana Datta; Shrabastee Chakraborty; Malini Basu; Mrinal K Ghosh
Journal:  Cells       Date:  2020-12-31       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.